FDA Inspection 1182340 - Taejoon Pharmaceutical Co., Ltd. - October 18, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Taejoon Pharmaceutical Co., Ltd., with an inspection on October 18, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Taejoon Pharmaceutical Co., Ltd.
Inspection Date: October 18, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 0a99edfc-34a3-45ad-affd-9bd3e671a129

Violation Codes1

21 CFR 211.160(b)

Full citation text and observation details available on the Dashboard.